National Institute of Neurological Disorders and Stroke; Notice of Meeting, 46880-46881 [05-15945]
Download as PDF
<![CDATA[
46880
Federal Register / Vol. 70, No. 154 / Thursday, August 11, 2005 / Notices
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: August 4, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–15942 Filed 8–10–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Diabetes
Complications in Animals.
Date: September 1, 2005.
Time: 11:00 a.m. to 1 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Maxine A. Lesniak, MPH,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 756, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7792. lesniakm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
VerDate jul<14>2003
16:14 Aug 10, 2005
Jkt 205001
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 4, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–15940 Filed 8–10–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging Bioengineering; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council for
Biomedical Imaging and Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering.
Date: September 14, 2005.
Open: 8 a.m. to 12:30 p.m.
Agenda: Report of the Director; Strategic
Plan Development; Training and Career
Development; Staff and Guest Speaker
Scientific Presentations.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Closed: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Mariott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Anthony Demsey, PhD,
Director, Office of Extramural Policy,
National Institute of Biomedical Imaging and
Bioengineering, 6701 Democracy Blvd, Room
241, Bethesda, MD 20892.
Any interested person may file
written comments with the committee
by forwarding the statement to the
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Contact Person listed on the notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/nacbib/
nacbib.htm, where an agenda and any
additional information for the meeting
be posted when available.
Dated: August 3, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–15943 Filed 8–10–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Child Health and
Human Development; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institutes of
Child Health and Human Development
Special Emphasis Panel, July 27, 2005,
1 p.m. to July 27, 2005, 1:30 p.m.
National Institutes of Health, 6100
Executive Boulevard, 5th Floor
Conference Room, Rockville, MD, 20852
which was published in the Federal
Register on July 22, 2005, 70 FR 42354.
The meting will be held August 9,
2005 at 12 p.m. to 12:30 p.m. The
meeting is closed to the public.
Dated: August 4, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–15944 Filed 8–10–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Neurological
Disorders and Stroke Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
E:\FR\FM\11AUN1.SGM
11AUN1
Federal Register / Vol. 70, No. 154 / Thursday, August 11, 2005 / Notices
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: September 15–16, 2005.
Open: September 15, 2005, 10:30 a.m. to 5
p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Research and other
administrative and program developments.
Place: National Instiutes of Health,
Building 31, 31 Center Drive, C Wing,
Conference Room 6, Bethesda, MD 20892.
Closed: September 16, 2005, 8 a.m. to 11:30
a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing
Conference Room 6, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance into the buiding by nongovernment employees. Persons without
a government I.D. will need to show a
photo I.D. and sign-in at the security
desk upon entering the building.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
VerDate jul<14>2003
16:14 Aug 10, 2005
Jkt 205001
Dated: August 4, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–15945 Filed 8–10–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Preclinical Animal
Studies for Autoimmunity.
Date: September 7, 2005.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Maxine A. Lesniak, MPH,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 756, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7792. lesniakm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Disease and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 5, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–15946 Filed 8–10–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases, Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the AIDS
Research Advisory Committee, NIAID.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: September 26, 2005.
Time: 1 p.m. to 4:30 p.m.
Agenda: Report from the Division Director
and other program staff.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Room E1/E2, Bethesda, MD
20892.
Contact Person: Rona L. Siskind, Executive
Secretary, AIDS Research Advisory
Committee, Division of AIDS NIAID/NIH,
6700B Rockledge Drive, Room 4139,
Bethesda, MD 20892–7601, 301–435–3732.
Any interested person may file
written comments with the committees
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance into the building by
nongovernment employees. Persons
without a government I.D. will need to
show a photo I.D. and sign-in at the
security desk upon entering the
building.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 5, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–15947 Filed 8–10–05; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
46881
E:\FR\FM\11AUN1.SGM
11AUN1
]]>Agencies
[Federal Register Volume 70, Number 154 (Thursday, August 11, 2005)]
[Notices]
[Pages 46880-46881]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15945]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Neurological Disorders and Stroke Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign
[[Page 46881]]
language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: September 15-16, 2005.
Open: September 15, 2005, 10:30 a.m. to 5 p.m.
Agenda: Report by the Director, NINDS; Report by the Director,
Division of Extramural Research and other administrative and program
developments.
Place: National Instiutes of Health, Building 31, 31 Center
Drive, C Wing, Conference Room 6, Bethesda, MD 20892.
Closed: September 16, 2005, 8 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C Wing Conference Room 6, Bethesda, MD 20892.
Contact Person: Robert Finkelstein, PhD, Associate Director for
Extramural Research, National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531,
Bethesda, MD 20892, (301) 496-9248.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the buiding by non-government employees.
Persons without a government I.D. will need to show a photo I.D. and
sign-in at the security desk upon entering the building.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: August 4, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-15945 Filed 8-10-05; 8:45 am]
BILLING CODE 4140-01-M
